Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

TB-Related Articles

Journal Articles Published by Division of TB Elimination (DTBE) Authors

The documents listed below are historical, archived information. The information contained in these documents, while accurate at the time of release, may not be the most current available.

January - December 2007

Akksilp S, Karnkawinpong O, Wattanaamornkiat W, Viriyakitja D, Monkongdee P, Sitti W, Rienthong D, Siraprapasiri T, Wells CD, Tappero JW, Varma JK. Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand. Emerg Infect Dis 2007 Jul; 13 (7): 1001-1007.

Andre M, Ijaz K, Tillinghast JD, Krebs VE, Diem LA, Metchock B, Crisp T, McElroy PD. Transmission network analysis to complement routine tuberculosis contact investigations. American Journal of Public Health 2007 Mar; 97(3):470-477.

Baumann MH, Nolan R, Petrini M, Lee YCG, Light RW, Schneider E. Pleural tuberculosis in the United States: incidence and drug resistance. Chest Apr 2007: 1125–1132.

Benator DA, Weiner MH, Burman WJ, Vernon AA, Zhao ZA, Khan AE, Jones BE, Sandman L, Engle M, Silva-Trigo C, Hsyu PH, Becker MI, Peloquin CA, for the Tuberculosis Trials Consortium. Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infection. Pharmacotherapy 2007 Jun; 27(6):793-800.

Bock NN, Jensen PA, Miller B, Nardell E. Tuberculosis infection control in resource-limited settings in the era of expanding HIV care and treatment. J Infect Dis 2007;196 Suppl 1:S108-13.

Cain KP, Haley CA, Armstrong LR, Garman KN, Wells CD, Iademarco MF, Castro KG, Laserson KF. Tuberculosis among foreign-born persons in the United States: achieving tuberculosis elimination. Am J Respir Crit Care Med 2007; 175: 75-79.

Cain KP, Kanara N, Laserson KF, Vannarith C, Sameourn K, Samnang K, Qualls ML, Wells CD, Varma JK. The epidemiology of HIV-associated tuberculosis in rural Cambodia. Int J Tuberc Lung Dis 2007;11:1008-13.

Castro KG. Tuberculosis surveillance: data for decision-making [editorial]. Clinical Infectious Diseases 2007 May 15; 44: 1268-70.

Cheruvu M, Plikaytis BB, Shinnick TM. The acid-induced operon Rv3083–Rv3089 is required for growth of Mycobacterium tuberculosis in macrophages. Tuberculosis 2007; 87: 12-20.

Conwell DS, Mosher A, Khan A, Tapy J, Sandman L, Vernon A, Horsburgh CR Jr. Factors associated with loss to follow-up in a large tuberculosis treatment trial (TBTC Study 22). Contemporary Clinical Trials 2007 May; 28(3):288-294.

Cooksey RC, de Waard JH, Yakrus MA, Toney SR, Da Mata O, Nowicki S, Sohner K, Koch E, Petti CA, Morey RE, Srinivasan A. Mycobacterium cosmeticum, Ohio and Venezuela [letter]. Emerg Infect Dis 2007 Aug; 13 (8): 1267-1269.

Dewan PK, Grinsdale J, Kawamura LK. Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis. Clinical Infectious Diseases 2007 Jan 1; 44(1): 69-73.

Driver CR. Kreiswirth B. Macaraig M. Clark C. Munsiff SS. Driscoll J. Zhao B. Molecular epidemiology of tuberculosis after declining incidence, New York City, 2001-2003. Epidemiology & Infection. 135(4):634-43, 2007 May.

Ferroussier O, Kumar MKA, Dewan PK, Nair PKJ, Sahu S, Wares DF, Laserson K, Wells C, Granich R, Chauhan LS. Cost and cost-effectiveness of a public-private mix project in Kannur District, Kerala, India, 2001-2002. Int J Tuberc Lung Dis 2007; 11 (7): 755-761.

Frieden TR, Munsiff SS, Desai Ahuja S. Outcomes of multidrug-resistant tuberculosis treatment in HIV-positive patients in New York City, 1990-1997 [letter]. Int J Tuberc Lung Dis January 2007; 11 (1): 116.

Fu LM, Shinnick TM. Genome-wide exploration of the drug action of capreomycin on Mycobacterium tuberculosis using Affymetrix oligonucleotide GeneChips. Journal of Infection 2007 Mar; 54(3):277-284.

Fu LM, Shinnick TM. Understanding the action of INH on a highly INH-resistant Mycobacterium tuberculosis strain using Genechips. Tuberculosis 2007; 87:63-70.

Haddad MB, Diem LA, Cowan LS, Cave MD, Bettridge J, Yun L, Winkler CS, Ingman DD, Oemig TV, Lynch A, Montero JT, McCombs SB, Ijaz K. Tuberculosis genotyping in six low-incidence states, 2000–2003. Am J Prev Med 2007 Mar; 32(3): 239–243.

Holtz TH. XDR-TB in South Africa: revised definition. [Letter] PLoS Medicine / Public Library of Science 2007 April; 4(4):e161.

Holtz TH, Cegielski JP. Origin of the term XDR-TB. European Respiratory Journal 2007; 30(2): 396.

Ijaz K, McElroy PD, Jereb J, Navin TR, Castro KG. Safety of the rifampin and pyrazinamide short-course regimen for treating latent tuberculosis infection [comment]. Clinical Infectious Diseases 2007 Feb 1; 44(3):464-5.

Katz D, Albalak R, Wing JS, Combs V, for the Tuberculosis Epidemiologic Studies Consortium. Setting the agenda: A new model for collaborative tuberculosis epidemiologic research. Tuberculosis 2007; 87: 1-6.

Li J, Marks SM, Driver CR, Diaz FA, Castro AF, de Regner AF, Gibson AE, Dokubo-Okereke K, Munsiff SS, TB Epidemiologic Studies Consortium. Human immunodeficiency virus counseling, testing, and referral of close contacts to patients with pulmonary TB: feasibility and costs. J Public Health Management Practice 2007; 13(3): 252-62.

Mazurek GH, Weis SE, Moonan PK, Daley CL, Bernardo J, Lardizabal AA, Reves RR, Toney SR, Daniels LJ, LoBue PA. Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis. Clin Infect Dis 2007;45:837-45.

Mazurek GH, Zajdowicz MJ, Hankinson AL, Costigan DJ, Toney SR, Rothel JS, Daniels LJ, Pascual FB, Shang N, Keep LW, LoBue PA. Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays. Clin Infect Dis 2007;45:826-36.

Miranda A, Morgan M, Jamal L, Laserson K, Barreira D, et al. Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995–2001. PLoS ONE 2007; 2(9): e826.

Riekstina V, Leimane V, Holtz TH, Leimans J, Wells CD. Treatment outcome cohort analysis in an integrated DOTS and DOTS-Plus TB program in Latvia. Int J Tuberc Lung Dis May 2007; 11(5): 585-587.

Sable SB, Plikaytis BB, Shinnick TM. Tuberculosis subunit vaccine development: impact of physicochemical properties of mycobacterial test antigens. Vaccine 2007 Feb 19; 25(9):1553-66.

Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, Peloquin CA, Gordin FM, Nunes D, Bernardo J, Venkataramanan R, Sterling TR on behalf of the ATS Hepatotoxicity of Antituberculosis Therapy Subcommittee. Antituberculosis Drugs and Hepatotoxicity. [Letter] Am J Respir Crit Care Med 2007; 175: 858a-859.

Schneider DL and Lobato MN. Tuberculosis control among people in U.S. Immigration and Customs Enforcement custody. American Journal of Preventive Medicine 2007 July; 33 (1): 9-14.

Sehgal S, Dewan PK, Chauhan LS, Sahu S, Wares F, Granich R. Public-private mix TB activities in Meerut, Uttar Pradesh, North India: delivering DOTS via collaboration with private providers and non-governmental organizations. Indian Journal of Tuberculosis 2007 April; 54(2):79-83.

Shah NS, Wright A, Bai GH, Barrera L, Boulahbal F, Martin-Casabona N, Drobniewski F, Gilpin C, Havelkova M, Lepe R, Lumb R, Metchock B, Portaels F, Rodrigues MF, Rusch-Gerdes S, Van Deun A, Vincent V, Laserson K, Wells C, Cegielski JP. Worldwide emergence of extensively drug-resistant tuberculosis. Emerging Infectious Diseases 2007 Mar; 13(3):380-387.

Thoen CO and LoBue PA. Mycobacterium bovis tuberculosis: forgotten, but not gone [comment]. The Lancet 2007 April 14; 369 (9569): 1236-1237.

Walton W. New activities and resources for engaging all health care providers in TB elimination [editorial]. International Journal of Tuberculosis and Lung Disease March 2007; 11 (3): 246.

Weiner M, Burman W, Luo C-C, Peloquin CA, Engle M, Goldberg S, Agarwal V, and Vernon A. Effects of rifampin and multidrug-resistance gene polymorphism on concentrations of moxifloxacin. Antimicrobial Agents and Chemotherapy 2007 August; 51 (8): 2861-2866.

Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A, Castro KG, Weyer K, et al. HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis 2007;196 Suppl 1:S86-107.

Zhao Z. Early stopping clinical trials of binomial response with an exact group sequential method. Statistics in Medicine 2007 Apr 15; 26(8):1724-9.


Contact Us:
  • Centers for Disease Control and Prevention
    Division of Tuberculosis Elimination (DTBE)
    1600 Clifton Rd., NE
    MS E10
    Atlanta, GA 30333
  • 800-CDC-INFO
    TTY: (888) 232-6348
  • Contact CDC–INFO The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #